Search This Blog

Thursday, April 23, 2020

Edwards Lifesciences EPS beats by $0.29, beats on revenue

Edwards Lifesciences (NYSE:EW): Q1 Non-GAAP EPS of $1.51 beats by $0.29; GAAP EPS of $1.47 beats by $0.50.
Revenue of $1.13B (+13.8% Y/Y) beats by $100M.
https://seekingalpha.com/news/3563891-edwards-lifesciences-eps-beats-0_29-beats-on-revenue

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.